Remedy Meds
PrivateLast Round
Series A
Jun 11, 2026
Total Funding Raised
$22.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Remedy Meds is a healthtech company that provides a consumer virtual-care and pharmacy platform focusing on medical weight loss treatments and other specialty care areas.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedy Meds Comparables
Compare Remedy Meds with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thrive Health Group, Inc. | 92% | |
| Mochi Health | 91% | |
| Ivim Health | 89% |
Remedy Meds Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 11, 2026 | ||||
| Seed | Nov 14, 2025 |
Key People
Founding team and executive leadership
Remedy Meds Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norwest Venture Partners | Series A |
| L Catterton | Series A |
| Alpha Partners | Seed |
| Dynamism Capital | Seed |
| Gurtin Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2026
$20M round led by L Catterton
- Nov 14, 2025
$3M round with Gurtin Ventures and Alpha Partners
Remedy Meds Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Remedy Meds's valuation, stock price, and market status.
Is Remedy Meds a public or private company?
Remedy Meds is a private company.
What is the current stock price of Remedy Meds?
Remedy Meds is a private company with no public stock price. No recent secondary market data is available.
How much is Remedy Meds worth (valuation)?
Valuation information for Remedy Meds is not publicly available.
Can I buy Remedy Meds stock?
Remedy Meds shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Remedy Meds's last funding round?
Remedy Meds's most recent funding round was Series A on June 11, 2026.
Who are the main investors in Remedy Meds?
Key investors in Remedy Meds include L Catterton.
Will Remedy Meds IPO soon?
No public IPO plans have been announced for Remedy Meds.
How can I track Remedy Meds secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remedy Meds's secondary market activity and sign up for updates.